Pharmacotherapy for Comorbidities in Chronic Heart Failure: A Focus on Hematinic Deficiencies, Diabetes Mellitus and Hyperkalemia

Expert Opinion on Pharmacotherapy - United Kingdom
doi 10.1080/14656566.2016.1197201
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Prevalence and Outcomes of Anemia and Hematinic Deficiencies in Patients With Chronic Heart Failure

JAMA Cardiology
Cardiovascular MedicineCardiology
2016English

Diabetes Mellitus and Heart Failure

American Journal of Medicine
Medicine
2017English

Mild Hyperkalemia and Outcomes in Chronic Heart Failure: A Propensity Matched Study

International Journal of Cardiology
Cardiovascular MedicineCardiology
2010English

Diabetes Mellitus and Heart Failure: A Deadly Duo

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2017English

Impact of a Pharmacist-Led Cardiology Pharmacotherapy Clinic on Chronic Heart Failure Management

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2018English

Prognostic Value of Glycemic Variability in Patients With Decompensated Chronic Heart Failure and Diabetes Mellitus

Kardiologiya
Cardiovascular MedicineCardiology
2017English

Mechanisms of Formation and Progression of Chronic Heart Failure on the Background of Type 2 Diabetes Mellitus

EMERGENCY MEDICINE
2018English

Prognostic Impact of Comorbidities in Hospitalized Patients With Acute Exacerbation of Chronic Heart Failure

European Journal of Internal Medicine
Internal Medicine
2016English

Renin Angiotensin Aldosterone System Inhibitors and Hyperkalemia in Acute Heart Failure

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy